CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 282 filers reported holding CYTOKINETICS INC in Q3 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2024 | $356,299 | -20.5% | 5,082 | -5.3% | 0.02% | -23.8% |
Q4 2023 | $448,007 | +183.4% | 5,366 | 0.0% | 0.02% | +162.5% |
Q3 2023 | $158,082 | -4.7% | 5,366 | +5.5% | 0.01% | 0.0% |
Q2 2023 | $165,938 | +3.5% | 5,087 | +11.7% | 0.01% | 0.0% |
Q1 2023 | $160,255 | -30.8% | 4,554 | -9.9% | 0.01% | -20.0% |
Q4 2022 | $231,483 | -1.7% | 5,052 | +4.0% | 0.01% | -16.7% |
Q3 2022 | $235,419 | +23.3% | 4,859 | 0.0% | 0.01% | +50.0% |
Q2 2022 | $190,910 | +6.7% | 4,859 | 0.0% | 0.01% | +33.3% |
Q1 2022 | $178,860 | -81.3% | 4,859 | -76.9% | 0.01% | -53.8% |
Q4 2021 | $956,724 | +27.5% | 20,990 | 0.0% | 0.01% | +18.2% |
Q3 2021 | $750,183 | +89.5% | 20,990 | +4.9% | 0.01% | +83.3% |
Q2 2021 | $395,978 | -9.2% | 20,009 | +6.7% | 0.01% | -14.3% |
Q1 2021 | $436,265 | +7.5% | 18,756 | -4.0% | 0.01% | +16.7% |
Q4 2020 | $405,958 | -4.0% | 19,536 | 0.0% | 0.01% | -14.3% |
Q3 2020 | $422,954 | +4.2% | 19,536 | +13.5% | 0.01% | 0.0% |
Q2 2020 | $405,781 | +86.0% | 17,216 | -7.0% | 0.01% | +40.0% |
Q1 2020 | $218,186 | +16.3% | 18,506 | +4.7% | 0.01% | +66.7% |
Q4 2019 | $187,542 | -13.5% | 17,676 | -7.3% | 0.00% | -25.0% |
Q3 2019 | $216,926 | +28.6% | 19,062 | +27.1% | 0.00% | +33.3% |
Q2 2019 | $168,682 | +49.8% | 14,994 | +7.7% | 0.00% | +50.0% |
Q1 2019 | $112,605 | +11.7% | 13,919 | -12.7% | 0.00% | 0.0% |
Q4 2018 | $100,779 | -25.4% | 15,946 | +16.3% | 0.00% | 0.0% |
Q3 2018 | $135,044 | -99.9% | 13,710 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $113,793,000 | +15.3% | 13,710 | 0.0% | 0.00% | +100.0% |
Q1 2018 | $98,712,000 | +88035.7% | 13,710 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $112,000 | -71.1% | 13,710 | -48.7% | 0.00% | -50.0% |
Q3 2017 | $387,000 | +19.8% | 26,716 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $323,000 | -5.8% | 26,716 | 0.0% | 0.00% | 0.0% |
Q1 2017 | $343,000 | +2.7% | 26,716 | -2.7% | 0.00% | 0.0% |
Q4 2016 | $334,000 | +32.5% | 27,453 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $252,000 | -3.4% | 27,453 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $261,000 | +34.5% | 27,453 | 0.0% | 0.00% | +100.0% |
Q1 2016 | $194,000 | -32.4% | 27,453 | 0.0% | 0.00% | -50.0% |
Q4 2015 | $287,000 | +84.0% | 27,453 | +17.6% | 0.00% | +100.0% |
Q3 2015 | $156,000 | -1.9% | 23,341 | -1.4% | 0.00% | 0.0% |
Q2 2015 | $159,000 | -20.9% | 23,662 | -20.1% | 0.00% | 0.0% |
Q1 2015 | $201,000 | +179.2% | 29,625 | +229.4% | 0.00% | – |
Q4 2014 | $72,000 | -68.4% | 8,993 | -62.5% | 0.00% | -100.0% |
Q1 2014 | $228,000 | +46.2% | 24,009 | +16.5% | 0.00% | +100.0% |
Q3 2013 | $156,000 | -34.5% | 20,612 | 0.0% | 0.00% | -50.0% |
Q2 2013 | $238,000 | – | 20,612 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |